Skip to main content
. 2020 Sep 17;10:15306. doi: 10.1038/s41598-020-72205-1

Table 1.

Demographic, clinical, and laboratory characteristics of the KFD patients recruited in the study.

Variable Mean (SD) N (%) H/O KFDV Vaccination
No (n = 22) Yes (n = 22) P value
Mean age in year 40.93 (13.1)
Gender
Male 18 (40.9) 11 7 0.3454
Female 26 (59.1) 11 15 0.4328
Hospitals
CHC Valpoi, Goa 23 (52.3) 15 8 0.1444
JCH Thirthahalli, Karnataka 13 (29.5) 2 11 0.0125
RH Dodamarg, SDH Sawanthwad, PHC Banda Maharashtra 8 (18.2) 5 3 0.4795
Socio economic status#
Low < 40 27 (61.3) 14 13 0.8474
Middle 40–70 17 (38.7) 8 9 0.8084
Clinical status (n = 44)
Fever 44 (100) 22 22 1.0
Myalgia 39 (88.6) 18 22 0.108
General weakness 37 (84.1) 19 19 1.0
Headache 37 (84.1) 20 18 0.664
Nausea 26 (59.1) 12 15 0.537
Cough 20 (45.5) 9 12 0.547
Vomiting 14 (31.2) 10 5 0.203
Diarrhoea 12 (27.3) 7 5 0.736
Altered sensorium and/or seizure 3 (6.8) 3 0 0.233
Hemorrhagic signs 1 (2.3) 1 0 1.0
Hypotension 18 (40.9) 9 11 0.763
Deceased 2 (4.5) 2 0 0.488
Laboratory features
Mean total leukocyte count/mm3 (n = 41) 2,588 (1627) 2,339 2,825 0.345
Mean platelet count × 103/µl (n = 39) 124 (50) 104 139 0.031*
Aspartate aminotransferase IU/L (n = 25) 208.7 (338) 326 80 0.681
Alanine aminotransferase IU/L (n = 25) 102.6 (136) 147 54.6 0.907
Alkaline phosphatase IU/L (n = 23) 211 (92.9) 222.3 196.8 0.525
C-Reactive protein < 10 mg/dl (N = 24) 2.6 (2.2) 2.49 2.8 0.733
Mean duration hospitalization (days) (n = 43) 5.2 (2.7) 5.04 5.4 0.653
H/O of KFD vaccination
Unvaccinated 22 (50)
Vaccinated at least one dose 22 (50)
Vaccinated two/three dose 16 (36.4)

*Significant difference, #modified Udai Pareekh scale.